Effects of Tamoxifen on the Mutant Allele Burden and Disease Course in Patients with Myeloproliferative Neoplasms - Results of the Tamarin Study
Year: 2020
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Claire Harrison, Joanna Baxter, Rebecca H. Boucher, Thomas McKerrell, Aimee Jackson, Rachel S Fletcher, Adam J. Mead, Steve Knapper, Joanne Ewing, Nauman M Butt, Manish Jain, Sebastian Francis, Fiona J Clark, Jason Coppell, Mary Frances McMullin, Frances Wadelin, Srinivasan Narayanan, Dragana Milojkovic, Mark W. Drummond, Mallika Sekhar, Maike Paramor, James Roberts, Rachel Glover, Erica Harris, Luigi Grassi, Alba Rodriguez-Meira, Jason Carroll, José-Ezequiel Martín, Giuditta Corbizi Fattori, Zijian Fang, Anna L Godfrey, Simón Méndez-Ferrer
Institutions: Guy's and St Thomas' NHS Foundation Trust, University of Cambridge, Cancer Research UK Clinical Trials Unit, University of Birmingham, Wellcome/MRC Cambridge Stem Cell Institute, Cambridge University Hospitals NHS Foundation Trust, University of Oxford, MRC Weatherall Institute of Molecular Medicine, MRC Molecular Haematology Unit, Cardiff University, University Hospitals Birmingham NHS Foundation Trust, Clatterbridge Cancer Centre NHS Foundation Trust, St James's University Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Royal Devon and Exeter Hospital, Queen's University Belfast, University Hospital Southampton NHS Foundation Trust, Imperial College Healthcare NHS Trust, Beatson West of Scotland Cancer Centre, University College Hospital
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3097419984